Efficacy of duloxetine vs. placebo in mild, moderate, and more severely ill patients with major depressive disorder

被引:0
|
作者
Prakash, A.
Pons, A.
Shelton, R.
Mallinckrodt, C.
Robinson, M.
Wohlreich, M.
Raskin, J.
Detke, M.
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S246 / S246
页数:1
相关论文
共 50 条
  • [21] Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, Craig H.
    Watkin, John G.
    Liu, Chaofeng
    Wohlreich, Madelaine M.
    Raskin, Joel
    [J]. BMC PSYCHIATRY, 2005, 5 (1)
  • [22] Association of Additional Common Variants in COMT with Duloxetine Efficacy in Patients with Major Depressive Disorder
    Houston, John P.
    Kohler, Jared
    Ostbye, Katherine M.
    Heinloth, Alexandra N.
    Perlis, Roy
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 184S - 184S
  • [23] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, JJ
    Siegal, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 47S - 47S
  • [24] Duloxetine vs. placebo in patients with painful diabetic neuropathy
    Goldstein, DJ
    Lu, YL
    Detke, MJ
    Lee, TC
    Iyengar, S
    [J]. PAIN, 2005, 116 (1-2) : 109 - 118
  • [25] Duloxetine in the treatment of major depressive disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, CH
    Watkin, JG
    Liu, C
    Wohlreich, MM
    Raskin, J
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S175 - S175
  • [26] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Perahia, D
    Mohs, R
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 346 - 347
  • [27] Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
    Craig H Mallinckrodt
    John G Watkin
    Chaofeng Liu
    Madelaine M Wohlreich
    Joel Raskin
    [J]. BMC Psychiatry, 5
  • [28] Duloxetine vs. placebo in the treatment of elderly patients with MDD
    Robinson, M
    Wiltse, C
    Dinkel, J
    Siegel, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S107 - S107
  • [29] Duloxetine vs. placebo in the treatment of' elderly patients with MDD
    Raskin, J
    Wiltse, C
    Dinkel, J
    Siegal, A
    Sheikh, J
    Xu, J
    Rotz, B
    Mohs, R
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S135 - S136
  • [30] Effects of initial dosing strategies of duloxetine on tolerability and efficacy in patients with major depressive disorder
    Dunner, David L.
    Kornstein, Susan
    Whitmyer, Virgil
    Meyers, Adam
    Mallinckrodt, Craig
    Wohlreich, Madelaine
    Hollandbeck, Millie
    Greist, John
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S106 - S106